House Party, a consumer activation and experiential marketing company, has hired J Gregory Jester as chief financial officer (CFO). Jester has more than 20 years of senior financial and operational management experience, ranging from serving at Big Four public accounting firms to helping start-up, rapid growth and turn-around companies. He has extensive expertise in establishing and managing accounting and finance teams in both publicly traded and private companies as well as managing merger and acquisition (M&A), financing and investor relations activities.
Jester joins from Alvogen Group, where he functioned as senior vice president (SVP) and CFO. He directed all financial activities for two operating companies within Alvogen’s life sciences sector: Alvogen, a start-up development stage specialty pharmaceutical company with global development activities; and Norwich Pharmaceuticals, a US$40m turn-around pharmaceutical contract manufacturer/developer.
Prior to Alvogen, Jester worked as a vice president and CFO at Innovive Pharmaceuticals, where he established all financial and investor relations activities for this start-up development stage oncology company.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.